Strong geographic and stage fit for a pre-seed AI/biotech startup targeting France. The fund's focus on proof-of-concept acceleration and access to Big Pharma network aligns well with the venture's need for non-dilutive support and biopharma partnerships. However, the venture is not yet incorporated and the fund typically selects from a large pool of projects, so competition is high.